| Autor: |
Dykewicz CA; National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. cad3@cdc.gov, Kruszon-Moran D, McQuillan GM, Williams WW, Van Loon FP, Cossen C, Forghani B, Hadler SC |
| Jazyk: |
angličtina |
| Zdroj: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2001 Oct 15; Vol. 33 (8), pp. 1279-86. Date of Electronic Publication: 2001 Sep 20. |
| DOI: |
10.1086/322651 |
| Abstrakt: |
Data obtained in the third National Health and Nutrition Examination Survey (NHANES III), conducted during 1988-1994, were analyzed to determine the epidemiology of rubella seropositivity in the United States, including risk factors for low rubella seropositivity. Serological samples obtained from NHANES III study participants > or =6 years of age were tested for rubella IgG antibodies. "Rubella seropositivity" was defined as serum rubella IgG antibody level > or =10 IU by enzyme immunoassay. Overall, rubella seropositivity rates in the United States were 92% in persons aged 6-11 years, 83% in persons aged 12-19 years, 85% in persons aged 20-29 years, 89% in persons aged 30-39 years, and >or =93% in persons aged > or =40 years. The lowest rate (78%) of any United States birth cohort of the 20th century occurred among persons born from 1970-1974. Eliminating rubella and chronic rubella syndrome in the United States will require international efforts, including vaccination of preschool- and school-age children and all susceptible young adults. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
